C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it?
Kaski
Eur Heart J 2009;0:ehp435v1-ehp435.
FULL TEXT
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
Buckley et al.
ANN INTERN MED 2009;151:483-495.
ABSTRACT
| FULL TEXT
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand et al.
ANN INTERN MED 2009;151:496-507.
ABSTRACT
| FULL TEXT
Newer Antiphospholipid Antibodies Predict Adverse Outcomes in Patients With Acute Coronary Syndrome
Greco et al.
Am J Clin Pathol 2009;132:613-620.
ABSTRACT
| FULL TEXT
Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes
von Eynatten et al.
Diabetes 2009;58:2093-2099.
ABSTRACT
| FULL TEXT
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott et al.
JAMA 2009;302:37-48.
ABSTRACT
| FULL TEXT
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander et al.
JAMA 2009;302:49-57.
ABSTRACT
| FULL TEXT
Biomarkers and Cardiovascular Disease: Determining Causality and Quantifying Contribution to Risk Assessment
Shah and de Lemos
JAMA 2009;302:92-93.
FULL TEXT
The Report Card on Growth Differentiation Factor 15: Consistent Marks But Not Yet Ready for Promotion
Rohatgi and de Lemos
Circ Cardiovasc Genet 2009;2:209-211.
FULL TEXT
Impact of socioeconomic, behavioral and clinical risk factors on mortality
Rask et al.
J Public Health (Oxf) 2009;31:231-238.
ABSTRACT
| FULL TEXT
Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study
Brautbar et al.
Circ Cardiovasc Genet 2009;2:279-285.
ABSTRACT
| FULL TEXT
Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10 year cohort study in Glasgow, Scotland
Woodward et al.
Eur Heart J 2009;0:ehp115v1-ehp115.
ABSTRACT
| FULL TEXT
C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?
Hingorani et al.
Clin. Chem. 2009;55:239-255.
ABSTRACT
| FULL TEXT
Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity
Schumacher et al.
Hypertension 2009;53:150-157.
ABSTRACT
| FULL TEXT
Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
de Ruijter et al.
BMJ 2009;338:a3083-a3083.
ABSTRACT
| FULL TEXT
Evaluating cardiovascular risk assessment for asymptomatic people
Scott
BMJ 2009;338:a2844-a2844.
FULL TEXT
Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
Rosenzweig et al.
J. Clin. Endocrinol. Metab. 2008;93:3671-3689.
ABSTRACT
| FULL TEXT
Importance of a Patient's Personal Health History on Assessments of Future Risk of Coronary Heart Disease
Mainous et al.
J Am Board Fam Med 2008;21:408-413.
ABSTRACT
| FULL TEXT
Review: Endothelial progenitor cells: markers of vascular reparative capacity
Povsic and Goldschmidt-Clermont
Ther Adv Cardiovasc Dis 2008;2:199-213.
ABSTRACT
Effects of Socioeconomic Position on Inflammatory and Hemostatic Markers: A Life-Course Analysis in the 1958 British Birth Cohort
Tabassum et al.
Am J Epidemiol 2008;167:1332-1341.
ABSTRACT
| FULL TEXT
New cardiovascular risk determinants do exist and are clinically useful
Levinson
Eur Heart J 2008;29:1335-1335.
FULL TEXT
Cardiovascular Outcomes in the Outpatient Kidney Transplant Clinic: The Framingham Risk Score Revisited
Kiberd and Panek
CJASN 2008;3:822-828.
ABSTRACT
| FULL TEXT
Why traumatic leg amputees are at increased risk for cardiovascular diseases
Naschitz and Lenger
QJM 2008;101:251-259.
ABSTRACT
| FULL TEXT
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
Fang et al.
J Am Coll Cardiol 2008;51:810-815.
ABSTRACT
| FULL TEXT
New cardiovascular risk determinants do exist and are clinically useful
Smulders et al.
Eur Heart J 2008;29:436-440.
ABSTRACT
| FULL TEXT
New cardiovascular risk factors exist, but are they clinically useful?
Wang
Eur Heart J 2008;29:441-444.
ABSTRACT
| FULL TEXT
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease
Brevetti et al.
Eur Heart J 2008;29:224-230.
ABSTRACT
| FULL TEXT
Polycystic Ovarian Syndrome, Biomarkers, and Metformin: Research, Risk, and Reality
Sattar and Nelson
J. Clin. Endocrinol. Metab. 2008;93:34-36.
FULL TEXT
Risk assessment in the patient with established peripheral arterial disease
Haugen et al.
Vasc Med 2007;12:343-350.
ABSTRACT
Rate of Change and Instability in Body Mass Index, Insulin Resistance, and Lipid Metabolism as Predictors of Atherosclerotic Vascular Disease
Christen et al.
J. Clin. Endocrinol. Metab. 2007;92:3780-3787.
ABSTRACT
| FULL TEXT
Cardiovascular Biomarkers: Added Value With an Integrated Approach?
Koenig
Circulation 2007;116:3-5.
FULL TEXT
Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study
Cao et al.
Circulation 2007;116:32-38.
ABSTRACT
| FULL TEXT
Prediction of Coronary Heart Disease Risk using a Genetic Risk Score: The Atherosclerosis Risk in Communities Study
Morrison et al.
Am J Epidemiol 2007;166:28-35.
ABSTRACT
| FULL TEXT
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
Ridker
J Am Coll Cardiol 2007;49:2129-2138.
ABSTRACT
| FULL TEXT
The Prognostic Accuracy of Coronary Calcification
Guerci
J Am Coll Cardiol 2007;49:1871-1873.
FULL TEXT
The Year in Atherothrombosis
Sanz et al.
J Am Coll Cardiol 2007;49:1740-1749.
FULL TEXT
C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Sattar et al.
Circulation 2007;115:981-989.
ABSTRACT
| FULL TEXT
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook
Circulation 2007;115:928-935.
ABSTRACT
| FULL TEXT
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker et al.
JAMA 2007;297:611-619.
ABSTRACT
| FULL TEXT
Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for 'Prime Time'
Steinberg and Mayer
Mayo Clin Proc. 2007;82:155-157.
FULL TEXT
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang et al.
NEJM 2006;355:2631-2639.
ABSTRACT
| FULL TEXT
Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Young et al.
Diabetes Care 2006;29:2688-2693.
ABSTRACT
| FULL TEXT
Lp-PLA2: A New Kid on the Block
Zalewski et al.
Clin. Chem. 2006;52:1645-1650.
ABSTRACT
| FULL TEXT
Nontraditional CHD Risk Markers: How Much Value Do They Add?
Journal Watch Cardiology 2006;2006:1-1.
FULL TEXT
C-Reactive Protein: Not Ready for Population-Wide CVD Risk Assessment
JWatch General 2006;2006:1-1.
FULL TEXT
Predicting cardiovascular risk: so what do we do now?
Lloyd-Jones and Tian
Arch Intern Med 2006;166:1342-1344.
FULL TEXT